PL2234605T3 - Transdermalny system terapeutyczny zawierający mocznik - Google Patents

Transdermalny system terapeutyczny zawierający mocznik

Info

Publication number
PL2234605T3
PL2234605T3 PL08871775T PL08871775T PL2234605T3 PL 2234605 T3 PL2234605 T3 PL 2234605T3 PL 08871775 T PL08871775 T PL 08871775T PL 08871775 T PL08871775 T PL 08871775T PL 2234605 T3 PL2234605 T3 PL 2234605T3
Authority
PL
Poland
Prior art keywords
therapeutic system
transdermal therapeutic
urea components
urea
components
Prior art date
Application number
PL08871775T
Other languages
English (en)
Polish (pl)
Inventor
Michael Horstmann
Gerd Hoffmann
Sandra Wiedersberg
Original Assignee
Lts Lohmann Therapie Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie Systeme Ag filed Critical Lts Lohmann Therapie Systeme Ag
Publication of PL2234605T3 publication Critical patent/PL2234605T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL08871775T 2008-01-30 2008-12-09 Transdermalny system terapeutyczny zawierający mocznik PL2234605T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102008006791A DE102008006791B4 (de) 2008-01-30 2008-01-30 Transdermales Therapeutisches System mit Harnstoff-Komponente und Verfahren zu dessen Herstellung
PCT/EP2008/010426 WO2009095057A2 (de) 2008-01-30 2008-12-09 Transdermales therapeutisches system mit harnstoff-komponente
EP08871775.6A EP2234605B1 (de) 2008-01-30 2008-12-09 Transdermales therapeutisches system mit harnstoff-komponente

Publications (1)

Publication Number Publication Date
PL2234605T3 true PL2234605T3 (pl) 2016-01-29

Family

ID=40386379

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08871775T PL2234605T3 (pl) 2008-01-30 2008-12-09 Transdermalny system terapeutyczny zawierający mocznik

Country Status (14)

Country Link
US (1) US9066887B2 (enExample)
EP (1) EP2234605B1 (enExample)
JP (1) JP5389824B2 (enExample)
KR (1) KR20100105866A (enExample)
CN (1) CN101909607B (enExample)
AU (1) AU2008349007B2 (enExample)
BR (1) BRPI0821975B8 (enExample)
CA (1) CA2710640C (enExample)
DE (1) DE102008006791B4 (enExample)
ES (1) ES2548295T3 (enExample)
MX (1) MX2010008334A (enExample)
PL (1) PL2234605T3 (enExample)
WO (1) WO2009095057A2 (enExample)
ZA (1) ZA201004012B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106333939A (zh) * 2016-10-09 2017-01-18 常州亚环环保科技有限公司 一种药用透皮材料的制备方法
CN109549929A (zh) * 2017-09-27 2019-04-02 天津金耀集团有限公司 一种有机固体溶液降低皮质激素药物粒径的方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1404583A (en) * 1971-10-08 1975-09-03 Vymatt Sa Urea compositions and methods of preparation thereof
CS164542B1 (enExample) * 1973-02-15 1975-11-07
DE2964135D1 (en) * 1978-06-16 1983-01-05 Phares Pharm Res Nv Pharmaceutical compositions containing urea
US4687481A (en) * 1984-10-01 1987-08-18 Biotek, Inc. Transdermal drug delivery system
US4699777A (en) * 1985-08-21 1987-10-13 Schering Corporation Compositions and method for enhancement of the transdermal flux of albuterol with a combination of 1-dodecyl-azacyclopheptan-2-one and urea
US5230896A (en) * 1989-10-12 1993-07-27 Warner-Lambert Company Transdermal nicotine delivery system
DE4210165A1 (de) 1991-07-30 1993-02-04 Schering Ag Transdermale therapeutische systeme
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
WO1997039740A1 (en) 1996-04-22 1997-10-30 Toyama Chemical Co., Ltd. Patch containing 1,2-ethanediol derivatives or salts thereof
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
FR2761889B1 (fr) 1997-04-11 1999-12-31 Oreal Patch pharmaceutique, cosmetique ou dermo-pharmaceutique pour la delivrance de plusieurs composes actifs de nature differente
US20040018241A1 (en) * 1997-09-26 2004-01-29 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
GB9826656D0 (en) * 1998-12-03 1999-01-27 Novartis Ag Organic compounds
JP3962684B2 (ja) * 2000-11-06 2007-08-22 サムヤン コーポレイション 改善された水分吸収能および接着性を有する経皮投与剤
IL156353A0 (en) * 2000-12-15 2004-01-04 Schering Ag Water-free skin care formulations comprising micronized urea and method of manufacturing the same
US20050020658A1 (en) 2002-11-21 2005-01-27 Katsuyuki Inoo Selective cyclooxygenase-2 inhibitor patch
FR2867978B1 (fr) * 2004-03-29 2009-02-20 Galderma Res & Dev Patch d'amorolfine pour le traitement de l'onychomicose
DE102004028284A1 (de) * 2004-06-11 2006-01-05 Hexal Ag Matrixkontrolliertes transdermales therapeutisches System auf Basis eines Schmelzklebstoffs zur Anwendung von Norelgestromin

Also Published As

Publication number Publication date
EP2234605A2 (de) 2010-10-06
BRPI0821975B8 (pt) 2023-02-07
CA2710640A1 (en) 2009-08-06
ZA201004012B (en) 2011-02-23
CN101909607A (zh) 2010-12-08
AU2008349007B2 (en) 2014-10-02
BRPI0821975B1 (pt) 2019-10-08
ES2548295T3 (es) 2015-10-15
CN101909607B (zh) 2014-05-14
US9066887B2 (en) 2015-06-30
WO2009095057A3 (de) 2010-03-04
AU2008349007A1 (en) 2009-08-06
DE102008006791A1 (de) 2009-08-06
HK1151716A1 (en) 2012-02-10
US20100310634A1 (en) 2010-12-09
MX2010008334A (es) 2010-08-23
JP2011510936A (ja) 2011-04-07
KR20100105866A (ko) 2010-09-30
BRPI0821975A2 (pt) 2015-06-23
EP2234605B1 (de) 2015-08-05
DE102008006791B4 (de) 2011-11-24
WO2009095057A2 (de) 2009-08-06
CA2710640C (en) 2015-12-08
JP5389824B2 (ja) 2014-01-15

Similar Documents

Publication Publication Date Title
EP2240236A4 (en) SKIN THERAPY SYSTEM
IL212826A (en) Edible Healing Operator System
GB0811304D0 (en) Therapeutic agents
EP2240244A4 (en) TRANSDERMIC MICROPASTILLE
IL206654A0 (en) Combination therapy
IL211293A0 (en) Combination therapy for tuberculosis
GB0819593D0 (en) Therapeutic agents
GB0813740D0 (en) Therapeutic compounds
GB0806794D0 (en) Therapeutic compounds
ZA201005663B (en) Transdermal therapeutic system having stabilized membrane
GB0804755D0 (en) Therapeutic compounds
GB0801081D0 (en) Therapeutic agents
GB0821693D0 (en) Therapeutic agents
GB0801080D0 (en) Therapeutic agents
GB0812309D0 (en) Therapeutic agents
GB0805818D0 (en) Therapeutic agents
ZA201006616B (en) Self-destrucing transdermal therapeutic system having improved functionality and efficacy
ZA200809004B (en) Autodestructive transdermal therapeutic system
GB0802201D0 (en) Treatment system
ZA201004012B (en) Transdermal therapeutic system having urea components
GB0803948D0 (en) Combination therapy
EP2485719A4 (en) TRANSDERMAL THERAPEUTIC SYSTEM
GB0823273D0 (en) Treatment system
EP2454276A4 (en) THERAPEUTIC AGENTS
EP2293729A4 (en) FASTENING SYSTEM